PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers

Overview of attention for article published in Clinical Cardiology: International Journal for Cardiovascular Diseases, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#20 of 2,551)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 20 news outlets
policy: 1 policy source
twitter: 39 X users

facebook: 3 Facebook pages
wikipedia: 3 Wikipedia pages

Readers on

mendeley: 75 Mendeley

So far, Altmetric has seen 3 public wall posts from 3 users.

Dr. James A. Underberg MD Cholesterol Specialist/Lipidologist, 09 Apr 2017

#PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers…

Partnership to Advance Cardiovascular Health, 22 Mar 2017

PACH was proud to partner with the American Society for Preventive Cardiology to help produce their first 2017 town hall on…

American Society for Preventive Cardiology, 22 Mar 2017

ASPC publishes pragmatic article on eliminating access barriers to PCSK9 inhibitors that includes tools and resources to help…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.